These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2703402)

  • 41. Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia.
    Urtasun RC; Chapman JD; Raleigh JA; Franko AJ; Koch CJ
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1263-7. PubMed ID: 3017905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Joint oxygen-glucose deprivation as the cause of necrosis in a tumor analog.
    Hlatky L; Sachs RK; Alpen EL
    J Cell Physiol; 1988 Feb; 134(2):167-78. PubMed ID: 3279056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.
    Rasey JS; Krohn KA; Grunbaum Z; Conroy PJ; Bauer K; Sutherland RM
    Radiat Res; 1985 Apr; 102(1):76-85. PubMed ID: 3983371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
    Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J
    Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Misonidazole binding in murine liver tissue: a marker for cellular hypoxia in vivo.
    Maxwell AP; MacManus MP; Gardiner TA
    Gastroenterology; 1989 Nov; 97(5):1300-3. PubMed ID: 2792663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.
    Skov KA; Adomat H; Chaplin DJ; Farrell NP
    Anticancer Drug Des; 1990 Feb; 5(1):121-8. PubMed ID: 2156514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and cytotoxicity of RSU-1069 in subcutaneous 9L tumours under oxic and hypoxic conditions.
    Wong KH; Koch CJ; Wallen CA; Wheeler KT
    Br J Cancer; 1991 Apr; 63(4):484-8. PubMed ID: 2021530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding of misonidazole to EMt6 and V79 spheroids.
    Franko AJ; Chapman JD; Koch CJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):737-9. PubMed ID: 7107407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
    Mulcahy RT
    Cancer Res; 1984 Oct; 44(10):4409-13. PubMed ID: 6467202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I; Guttman P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):663-6. PubMed ID: 7107395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S.
    Pettersen EO; Lindmo T
    Br J Cancer; 1981 Mar; 43(3):355-66. PubMed ID: 7013776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouse.
    Cobb LM; Nolan J; Butler S
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):347-51. PubMed ID: 2303365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
    Huang T; Civelek AC; Li J; Jiang H; Ng CK; Postel GC; Shen B; Li XF
    J Nucl Med; 2012 Aug; 53(8):1262-8. PubMed ID: 22717978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxygen dependence for chemosensitization by misonidazole.
    Roizin-Towle L; Hall EJ; Pirro JP
    Br J Cancer; 1986 Dec; 54(6):919-24. PubMed ID: 3801287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
    Raleigh JA; Franko AJ; Koch CJ; Born JL
    Br J Cancer; 1985 Feb; 51(2):229-35. PubMed ID: 3966980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro binding of 14C-misonidazole to hepatocytes and hepatoma cells.
    Van Os-Corby DJ; Chapman JD
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1251-4. PubMed ID: 3744947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.
    Parliament MB; Wiebe LI; Franko AJ
    Br J Cancer; 1992 Dec; 66(6):1103-8. PubMed ID: 1280990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.